Decentralized Clinical Trials Market Report 2022-2032

Visiongain
VISION10142
$5,119.00

According to our analysis, global decentralized clinical trials market was valued at US$xx million in 2021 and is expected to grow at a CAGR of xx% during the forecast period 2022-2032 to reach US$xx million by 2032.


This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.


Key Questions Answered by this Report:

• What is the current size of the overall global decentralized clinical trials market? How much will this market be worth from 2022 to 2032?

• What are the main drivers and restraints that will shape the overall decentralized clinical trials market over the next ten years?

• What are the main segments within the overall decentralized clinical trials market?

• How much will each of these segments be worth for the period 2022 to 2032?

• How will the composition of the market change during that time, and why?

• What factors will affect that industry and market over the next ten years?

• What are the largest national markets for the world decentralized clinical trials?

• What is their current status and how will they develop over the next ten years?

• What are their revenue potentials to 2032?

• How will political and regulatory forces influence regional markets?

• How will market shares of the leading national markets change by 2032, and which geographical region will lead the market in 2032?

• Who are the leading companies and what are their activities, results, developments and prospects?

• What are the leading decentralized clinical trials? What are their revenues and latest developments?

• What are some of the most prominent decentralized clinical trials currently in development?

• What are the main trends that will affect the world decentralized clinical trials market between 2022 and 2032?

• What are the main strengths, weaknesses, opportunities and threats for the market?

• What are the social, technological, economic and political influences that will shape that industry over the next ten years?

• How will the global decentralized clinical trials market evolve over the forecasted period, 2022 to 2032?

• What will be the main commercial drivers for the market from 2022 to 2032?

• How will market shares of prominent national markets change from 2022, and which countries will lead the market in 2032, achieving highest revenues and fastest growth?

• How will that industry evolve between 2022 and 2032, especially in R&D?



Advantages of decentralised trials is boosting the growth of global market. Find out why.

Decentralization has broadened trial access to reach a bigger number and perhaps a more diverse pool of patients, as 70 percent of eligible participants who often live more than two hours from trial sites. These various options enable a wide range of Decentralized and hybrid clinical-trial designs. In its most complete form, a trial can be totally virtual, with assessments and enrolment taking place in a patient's home, made possible by the self-administration of medicines and end-to-end digital tools. This totally virtual model is gradually transitioning from early-phase and post-approval trials to massive pivotal trials. While most clinical trials will not be completely virtual, they will employ one or more Decentralized features based on their end targets, patient demographics, and treatments. Many of these ingredients have been extensively tested, with 48 to 95 percent of sponsors reporting use in at least one Phase III trial. Convenience is becoming increasingly important for patient enrolment and retention in clinical trials, particularly those involving uncommon diseases. Patients and physicians anticipate that sponsors would include patient convenience in trial designs, and investigators in many countries predict an increase in patient-centric trial characteristics. Electronic patient-reported outcomes (ePROs) and Electronic clinical outcomes assessments (eCOAs) make use of digital platforms to obtain direct data from research stakeholders. As a result, there is much less paper recording and much timelier data, as well as more patient consistency. When clinical research associates are unable to physically attend an investigator site or clinic, virtual solutions for generating data analytics, enabling remote source data verification, and performing other monitoring activities are available. Thus, the growing popularity of Decentralized clinical trials due its advantages is driving the market growth.


Discover sales predictions for the global decentralized clinical trials market and submarkets

Over the last few years, decentralized clinical trials has gained widespread attention due to its high efficiency and adoption by pharmaceutical & biopharmaceutical companies. Along with revenue prediction for the overall world market, there are 3 segmentations of the Decentralized Clinical Trials market, with forecasts for 3 Study Design, 5 Indication, 3 End-User, each forecasted at a global, regional, and country level, along with COVID-19 impact recovery pattern analysis for all segments.


Who are the leading players analysed in the market?

• CASTOR EDC

• Clinical Ink, Inc. (G. I. Partners)

• CLOUDZBY, INC.

• Dassault SystemesSE (Medidata Solutions, Inc.)

• ERGOMED PLC

• Florence Healthcare, Inc.

• ICON PLC

• IQVIA Holdings, Inc.

• Laboratory Corporation of America Holdings (Covance, Inc.)

• Medable, Inc.

• Medrio Inc.

• Oracle Corporation

• Parexel International Corporation

• Pharmaceutical Product Development, Inc.

• Syneos Health

'

1 Report Overview
1.1 Introduction to Decentralised Clinical Trials Market
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered by This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.6.3 Market Evaluation &Forecast Methodology
1.7 Frequently Asked Questions (FAQs)
1.8 Associated Reports
1.9 About

2 Executive Summary

3 Market Dynamics
3.1 Drivers for Decentralised Clinical Trials Market
3.1.1 Advantages of Decentralised Trials is driving the Market
3.1.2 Increasing R&D expenditure of pharmaceutical and biopharmaceutical companies
3.1.3 Growing Adoption of Advanced Technologies is Boosting the Market Growth
3.1.4 COVID-19 Pandemic is driving the Adoption of Decentralised Clinical Trials
3.1.5 Rising Presence of CROs in Emerging Market is Boosting the Market Growth
3.2 Restraints for Decentralised Clinical Trials Market
3.2.1 Data Security Concerns Hinders the Market Growth
3.2.2 Complex Supply Chain and Manufacturing Could limit the Entry of New Players
3.3 Opportunities for Decentralised Clinical Trials Market
3.3.1 Evolution of Decentralised Trials Technologies is Projected to Boost the Market Growth
3.3.2 Introduction of Advanced Cloud Platform
3.3.3 Support from Government is estimated to propel the Market Growth
3.3.4 Mergers, Agreements, and Acquisitions by the Market Players is a Major Trend Witnessed in the Market
3.4 Challenges for Decentralised Clinical Trials Market
3.4.1 Challenges associated With Clinical Trials Logistics could limit its Adoption
3.4.2 Lack of Global; Standardisation for Decentralised Clinical Trials
3.5 SWOT Analysis for Decentralised Clinical Trials Market
3.5.1 Strengths: Decentralised Clinical Trials Market
3.5.1.1 Patient-Centric Approach is a Major Strengths
3.5.2 Weaknesses: Decentralised Clinical Trials Market
3.5.2.1 Lack of Standard Regulations is a Major Issue
3.5.3 Opportunities: Decentralised Clinical Trials Market
3.5.3.1 Technological Advancements is projected to Strengthen the Market Growth in Near Future
3.5.4 Threats: Decentralised Clinical Trials Market
3.5.4.1 Data Security and Privacy Risk Associated with DCTs
3.6 Porter’s Five Forces Analysis: Decentralised Clinical Trials Market
3.6.1 Bargaining Power of Supplier: Low
3.6.2 Bargaining Power of Buyer: Moderate
3.6.3 Competitive Rivalry: High
3.6.4 Threat of New Entrants: Moderate
3.6.5 Threat of Substitutes: Moderate
3.7 PEST Analysis: Decentralised Clinical Trials Market
3.7.1 Political Factors Impacting Decentralised Clinical Trials Market
3.7.2 Economic Factors Impacting Decentralised Clinical Trials Market
3.7.3 Social Factors Impacting Decentralised Clinical Trials Market
3.7.4 Technological Factors Impacting Decentralised Clinical Trials Market

4 COVID-19 Impact: Global Decentralised Clinical Trials Market
4.1 Global Decentralised Clinical Trials Market Forecast, 2022-2032
4.2 COVID-19 Impact Overview
4.3 "V" shaped Recovery - Rapid Decline - Sharp Borrow -Rapid Recovery
4.4 "U" Shaped Recovery -Rapid Decline Early Then Slow - Gradual at the Bottom - Slow Recovery at First - Faster Recovery Later On
4.5 "W" Shaped Recovery -Rapid Decline - Rapid Recovery- Return of Virus - Another Sharp Decline -Recovery
4.6 "L" Shaped Recovery - Rapid Decline - Then Slow Growth

5 Global Decentralised Clinical Trials Market Size Forecast 2022-2032 by Study Design
5.1 Global Interventional Study Design Segment: Revenue Forecast 2022-2032
5.1.1 Interventional Study Design is the Largest Revenue Grossing Segment
5.1.2 Global Decentralised Clinical Trials Market for Interventional Study Design Segment Forecast, 2022-2032: Recovery Forecasts (V, U, W, L)
5.2 Global Observational Study Design Segment: Revenue Forecast 2022-2032
5.2.1 Observational Study Design
5.2.2 Global Decentralised Clinical Trials Market for Observational Study Design Segment Forecast, 2022-2032: Recovery Forecasts (V, U, W, L)
5.3 Global Expanded Access Study Design Segment: Revenue Forecast 2022-2032
5.3.1 Expanded Access Study Design is a Promising form of Adoptive Decentralised Clinical Trials
5.3.2 Global Decentralised Clinical Trials Market for Expanded Study Design Segment Forecast, 2022-2032: Recovery Forecasts (V, U, W, L)

7 Global Decentralised Clinical Trials Market Size Forecast 2022-2032 by Indication
7.1 Oncology Segment: Revenue Forecast 2022-2032
7.1.1 Decentralised Oncology Trial Operations Could Result in Significant Increases in Representation and Accessibility
7.1.2 Global Decentralised Clinical Trials Market for Oncology Segment Forecast, 2022-2032: Recovery Forecasts (V, U, W, L)
7.2 Cardiovascular Segment: Revenue Forecast 2022-2032
7.2.1 DCTs enhanced the Logistics of Clinical Trials for Cardiovascular Indications
7.2.2 Global Decentralised Clinical Trials Market for Cardiovascular Segment Forecast, 2022-2032: Recovery Forecasts (V, U, W, L)
7.3 Immunology Segment: Revenue Forecast 2022-2032
7.3.1 Removing Impediments to Site Visits Improves Immunological Disorder Trial Retention
7.3.2 Global Decentralised Clinical Trials Market for Immunology Segment Forecast, 2022-2032: Recovery Forecasts (V, U, W, L)
7.4 Respiratory Segment: Revenue Forecast 2022-2032
7.4.1 COVID-19 Pandemic has propelled the Use of DCT in Respiratory Diseases Clinical Trials
7.4.2 Global Decentralised Clinical Trials Market for Respiratory Segment Forecast, 2022-2032: Recovery Forecasts (V, U, W, L)
7.5 Others Segment: Revenue Forecast 2022-2032
7.5.1 Growing Demand for Advanced Drugs Is Expected to Propel the Others Segment Growth
7.5.2 Global Decentralised Clinical Trials Market for Others Segment Forecast, 2022-2032: Recovery Forecasts (V, U, W, L)

8 Decentralised Clinical Trials Market by End-User Forecast, 2022-2032
8.1 Pharmaceutical & Biopharmaceutical Companies Segment Market Forecast, 2022-2032
8.1.1 Largest-Revenue Growing Segment in the Market
8.1.2 Global Decentralised Clinical Trials Market for Pharmaceutical & Biopharmaceutical Companies Segment Forecast, 2022-2032: Recovery Scenarios (V, U, W, L)
8.2 CROs Segment Market Forecast, 2022-2032
8.2.1 Second-Largest Revenue Generating Segment
8.2.2 Global Decentralised Clinical Trials Market for CRO’s Segment Forecast, 2022-2032: Recovery Scenarios (V, U, W, L)
8.3 Others Segment Market Forecast, 2022-2032
8.3.1 Well-defined Regulations for the Cellular Therapies in the Developed Countries Is Expected to Drive the Market Growth
8.3.2 Global Decentralised Clinical Trials Market for Others Segment Forecast, 2022-2032: Recovery Scenarios (V, U, W, L)

9 Global Decentralised Clinical Trials Market Forecast, By Geography 2022-2032
9.1 Global Decentralised Clinical Trials Market by Region Forecast 2022-2032
9.1 Global Decentralised Clinical Trials Market for Region Segment Forecast, 2022-2032: Recovery Scenarios (V, U, W, L)

10 North America Decentralised Clinical Trials Market, 2022-2032
10.1 North America is the Largest Revenue Grossing Region in the Global Market
10.2 North America Decentralised Clinical Trials Market by Country, Forecast 2022-2032
10.3 North America Decentralised Clinical Trials Market Forecast by Study Design
10.3.1 Recovery Scenarios (V, U, W, L): North America Decentralised Clinical Trials Market Forecast by Study Type, 2022-2032
10.4 North America Decentralised Clinical Trials Market Forecast by Indication
10.4.1 Recovery Scenarios (V, U, W, L): North America Decentralised Clinical Trials Market Forecast by Indication, 2022-2032
10.5 North America Decentralised Clinical Trials Market Forecast by End-User
10.5.1 Recovery Scenarios (V, U, W, L): North America Decentralised Clinical Trials Market Forecast by End-User, 2022-2032
10.6 U. S. Decentralised Clinical Trials Market Forecast, 2022-2032
10.6.1 Presence of Leading Players is a Major factor driving the U. S. Decentralised Clinical Trials Market
10.6.2 U. S. Decentralised Clinical Trials Market Growth is Primarily Attributable to Growing R&D Expenditure and Outsourcing Activities
10.6.3 Recovery Scenarios (V, U, W, L): U. S. Decentralised Clinical Trials Market Forecast, 2022-2032
10.7 Canada Decentralised Clinical Trials Market Forecast,2022-2032
10.7.1 Canada Market Anticipated to Witness the Fastest Growth in the North America Region
10.7.2 Growing Canadian research collaborations determined to Provide Infrastructure for Cell-Based Therapy Research
10.7.3 Recovery Scenarios (V, U, W, L): Canada Decentralised Clinical Trials Market Forecast, 2022-2032

11 Europe Decentralised Clinical Trials Market, 2022-2032
11.1 Second Largest Revenue Grossing Region in the Global Market
11.2 Europe Decentralised Clinical Trials Market by Country, Forecast 2022-2032
11.3 Europe Decentralised Clinical Trials Market Forecast by Study Design
11.3.1 Recovery Scenarios (V, U, W, L): Europe Decentralised Clinical Trials Market Forecast by Study Type, 2022-2032
11.4 Europe Decentralised Clinical Trials Market Forecast by Indication
11.4.1 Recovery Scenarios (V, U, W, L): Europe Decentralised Clinical Trials Market Forecast by Indication, 2022-2032
11.5 Europe Decentralised Clinical Trials Market Forecast by End-User
11.5.1 Recovery Scenarios (V, U, W, L): Europe Decentralised Clinical Trials Market Forecast by Indication, 2022-2032
11.6 Germany Decentralised Clinical Trials Market Forecast, 2022-2032
11.6.1 Germany Is Home to a Few of the Biggest Pharmaceutical Firms of the World that is Expected to Boost the Regional Market Growth
11.6.2 LINK Medical strengthens its position in Germany as a strategic gateway between Europe and the Nordics
11.6.3 Recovery Scenarios (V, U, W, L): Germany Decentralised Clinical Trials Market Forecast, 2022-2032
11.7 UK Decentralised Clinical Trials Market Forecast, 2022-2032
11.7.1 Presence of Well-Developed R&D Infrastructure
11.7.2 UK has been a Hub for Generics and Biosimilar Drugs Production and Development
11.7.3 Recovery Scenarios (V, U, W, L): UK Decentralised Clinical Trials Market Forecast, 2022-2032
11.8 France Decentralised Clinical Trials Market Forecast, 2022-2032
11.8.1 Rising Preference for France for Drug R&D and Manufacturing by Leading Players
11.8.2 Major Player focusing on Collaboration and product development strategies in this region
11.8.3 Recovery Scenarios (V, U, W, L): France Decentralised Clinical Trials Market Forecast, 2022-2032
11.9 Italy Decentralised Clinical Trials Market Forecast, 2022-2032
11.9.1 Pharmaceutical Manufacturing Hub
11.9.2 Italian Decentralised Clinical Trials Market Is the Fourth Biggest Market Within the European Region
11.9.3 Recovery Scenarios (V, U, W, L): Italy Decentralised Clinical Trials Market Forecast, 2022-2032
11.10 Spain Decentralised Clinical Trials Market Forecast, 2022-2032
11.10.1 Demand for Drugs Is Influenced by the Growth of the Pharmaceutical Industry
11.10.2 Spanish Economy Is Growing Strong
11.10.3 Recovery Scenarios (V, U, W, L): Spain Decentralised Clinical Trials Market Forecast, 2022-2032
11.11 Russia Decentralised Clinical Trials Market Forecast, 2022-2032
11.11.1 Unmet Pharmaceutical Needs
11.11.2 Russia’s attractiveness as a location for all types of clinical trial
11.11.3 Recovery Scenarios (V, U, W, L): Russia Decentralised Clinical Trials Market Forecast, 2022-2032
11.12 Rest of Europe Decentralised Clinical Trials Market Forecast, 2022-2032
11.12.1 Increasing Prevalence of Chronic Diseases Drives the Market Growth in this Region
11.12.2 Recovery Scenarios (V, U, W, L): Rest of Europe Decentralised Clinical Trials Market Forecast, 2022-2032

12 Asia Pacific Decentralised Clinical Trials Market, 2022-2032
12.1 Asia Pacific is the Fastest Growing Market
12.2 Asia Pacific Decentralised Clinical Trials Market by Country, Forecast 2022-2032
12.3 Asia Pacific Decentralised Clinical Trials Market Forecast by Study Design
12.3.1 Recovery Scenarios (V, U, W, L): Asia Pacific Decentralised Clinical Trials Market Forecast by Study Type, 2022-2032
12.4 Asia Pacific Decentralised Clinical Trials Market Forecast by Indication
12.4.1 Recovery Scenarios (V, U, W, L): Asia Pacific Decentralised Clinical Trials Market Forecast by Indication, 2022-2032
12.5 Asia Pacific Decentralised Clinical Trials Market Forecast by End-User
12.5.1 Recovery Scenarios (V, U, W, L): Asia Pacific Decentralised Clinical Trials Market Forecast by Indication, 2022-2032
12.6 Japan Decentralised Clinical Trials Market Forecast, 2022-2032
12.6.1 Japan Accounted for the Largest Market Share in the Asia Pacific Region
12.6.2 International CROs that Have Established Branches in Japan has propelled the Market Growth
12.6.3 Recovery Scenarios (V, U, W, L): Japan Decentralised Clinical Trials Market Forecast, 2022-2032
12.7 China Decentralised Clinical Trials Market Forecast, 2022-2032
12.7.1 Strategic Initiatives Undertaken by the Market Players
12.7.2 Increasing Healthcare Spending in China
12.7.3 Recovery Scenarios (V, U, W, L): China Decentralised Clinical Trials Market Forecast, 2022-2032
12.8 India Decentralised Clinical Trials Market Forecast, 2022-2032
12.8.1 Developing Healthcare Infrastructure
12.8.2 India Poised to conduct more Decentralised Clinical Trials
12.8.3 Recovery Scenarios (V, U, W, L): India Decentralised Clinical Trials Market Forecast, 2022-2032
12.9 Australia Decentralised Clinical Trials Market Forecast, 2022-2032
12.9.1 Australia Has as Long a History of Conducting High-Standard Clinical Trials
12.9.2 Availability Of High-End Healthcare Infrastructure
12.9.3 Recovery Scenarios (V, U, W, L): Australia Decentralised Clinical Trials Market Forecast, 2022-2032
12.10 South Korea Decentralised Clinical Trials Market Forecast, 2022-2032
12.10.1 Adoption of Advanced Solutions by Hospitals & CROs among People
12.10.2 Availability of Skilled Workforce is expected to drive the South Korea Market
12.10.3 Recovery Scenarios (V, U, W, L): South Korea Decentralised Clinical Trials Market Forecast, 2022-2032
12.11 Rest of Asia Pacific Decentralised Clinical Trials Market Forecast, 2022-2032
12.11.1 Rising Disposable Income
12.11.2 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Decentralised Clinical Trials Market Forecast, 2022-2032

13 Latin America Decentralised Clinical Trials Market, 2022-2032
13.1 Latin America Decentralised Clinical Trials Market
13.2 Latin America Decentralised Clinical Trials Market by Country, Forecast 2022-2032
13.3 Latin America Decentralised Clinical Trials Market Forecast by Study Design
13.3.1 Recovery Scenarios (V, U, W, L): Latin America Decentralised Clinical Trials Market Forecast by Study Type, 2022-2032
13.4 Latin America Decentralised Clinical Trials Market Forecast by Indication
13.4.1 Recovery Scenarios (V, U, W, L): Latin America Decentralised Clinical Trials Market Forecast by Indication, 2022-2032
13.5 Latin America Decentralised Clinical Trials Market Forecast by End-User
13.5.1 Recovery Scenarios (V, U, W, L): Latin America Decentralised Clinical Trials Market Forecast by Indication, 2022-2032
13.6 Brazil Decentralised Clinical Trials Market Forecast, 2022-2032
13.6.1 Fastest Growing Economy in Latin America
13.6.2 High Potential Manufacturing Environment
13.6.3 Recovery Scenarios (V, U, W, L): Brazil Decentralised Clinical Trials Market Forecast, 2022-2032
13.7 Mexico Decentralised Clinical Trials Market Forecast, 2022-2032
13.7.1 Lower Manufacturing Costs than In the U. S.
13.7.2 Strategic Initiatives Undertaken by Market Players
13.7.3 Recovery Scenarios (V, U, W, L): Mexico Decentralised Clinical Trials Market Forecast, 2022-2032
13.8 Rest of Latin America Decentralised Clinical Trials Market Forecast, 2022-2032
13.8.1 Evolving Healthcare Infrastructure in Latin America
13.8.2 Recovery Scenarios (V, U, W, L): Rest of Latin America Decentralised Clinical Trials Market Forecast, 2022-2032

14 MEA Decentralised Clinical Trials Market, 2022-2032
14.1 Rising Prevalence of Cancer in MEA Region
14.2 MEA Decentralised Clinical Trials Market by Country, Forecast 2022-2032
14.3 MEA Decentralised Clinical Trials Market Forecast by Study Design
14.3.1 Recovery Scenarios (V, U, W, L): MEA Decentralised Clinical Trials Market Forecast by Study Type, 2022-2032
14.4 MEA Decentralised Clinical Trials Market Forecast by Indication
14.4.1 Recovery Scenarios (V, U, W, L): MEA Decentralised Clinical Trials Market Forecast by Indication, 2022-2032
14.5 MEA Decentralised Clinical Trials Market Forecast by End-User
14.5.1 Recovery Scenarios (V, U, W, L): MEA Decentralised Clinical Trials Market Forecast by Indication, 2022-2032
14.6 South Africa Decentralised Clinical Trials Market Forecast, 2022-2032
14.6.1 Prevalence of Cancer in South Africa is Increasing Rapidly
14.6.2 Population Exposed to Mining Suffers from Cancer
14.6.3 Recovery Scenarios (V, U, W, L): South Africa Decentralised Clinical Trials Market Forecast, 2022-2032
14.7 GCC Decentralised Clinical Trials Market Forecast, 2022-2032
14.7.1 Presence of Huge Growth Opportunities
14.7.2 Advances in personalised medicine and immuno-oncology have ushered in a paradigm change
14.7.3 Recovery Scenarios (V, U, W, L): GCC Decentralised Clinical Trials Market Forecast, 2022-2032
14.8 Rest of MEA Decentralised Clinical Trials Market Forecast, 2022-2032
14.8.1 MEA DCT market is positioned as a new ally for the worldwide
14.8.2 Extensive Tobacco Use Increases Incidence of Cancer
14.8.3 Recovery Scenarios (V, U, W, L): Rest of MEA Decentralised Clinical Trials Market Forecast, 2022-2032

15 Company Profiles: Decentralised Clinical Trials Market
15.1 Decentralised Clinical Trials Market: Company Share Analysis
15.2 Decentralised Clinical Trials Market Recent Developments, 2018-2021
15.3 IQVIA Holdings, Inc.
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2016-2020
15.3.3.2 Regional Revenue/Market Shares, 2020
15.3.3.3 Segmental Revenue/Market Shares, 2020
15.3.4 Product Benchmarking
15.3.5 Recent Developments, 2018-2021
15.4 ICON PLC
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2016-2020
15.4.3.2 Regional Revenue/Market Shares, 2020
15.4.4 Product Benchmarking
15.4.5 Recent Developments, 2018-2021
15.5 Laboratory Corporation of America Holdings (Covance, Inc. )
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2016-2020
15.5.3.2 Regional Revenue/Market Shares, 2020
15.5.3.3 Segmental Revenue/Market Shares, 2020
15.5.4 Product Benchmarking
15.5.5 Recent Developments, 2018-2021
15.6 Dassault SystemesSE (Medidata Solutions, Inc. )
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2016-2020
15.6.3.2 Regional Revenue/Market Shares, 2020
15.6.3.3 Segmental Revenue/Market Shares, 2020
15.6.4 Product Benchmarking
15.6.5 Recent Developments, 2018-2021
15.7 Oracle Corporation
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2016-2020
15.7.3.2 Regional Revenue/Market Shares, 2020
15.7.3.3 Segmental Revenue/Market Shares, 2020
15.7.4 Product Benchmarking
15.7.5 Recent Developments, 2018-2021
15.8 Parexel International Corporation (Pamplona Capital Management)
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Product Benchmarking
15.8.4 Recent Developments, 2018-2021
15.9 Medrio Inc.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Product Benchmarking
15.9.4 Recent Developments, 2018-2021
15.10 Medable, Inc.
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Product Benchmarking
15.10.4 Recent Developments, 2018-2021
15.11 Clinical Ink, Inc. (G. I. Partners)
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Product Benchmarking
15.11.4 Recent Developments, 2018-2021
15.12 FLORENCE HEALTHCARE INC.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Product Benchmarking
15.12.4 Recent Developments, 2018-2021
15.13 Syneos Health
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Financial Analysis
15.13.3.1 Net Revenue, 2016-2020
15.13.3.2 Regional Revenue/Market Shares, 2020
15.13.3.3 Segmental Revenue/Market Shares, 2020
15.13.4 Product Benchmarking
15.13.5 Recent Developments, 2018-2021
15.14 Pharmaceutical Product Development, Inc.
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Financial Analysis
15.14.3.1 Net Revenue, 2016-2020
15.14.3.2 Regional Revenue/Market Shares, 2020
15.14.3.3 Segmental Revenue/Market Shares, 2020
15.14.4 Product Benchmarking
15.14.5 Recent Developments, 2018-2021
15.15 CASTOR EDC
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Product Benchmarking
15.15.4 Recent Developments, 2018-2021
15.16 CLOUDZBY, INC.
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Product Benchmarking
15.16.4 Recent Developments, 2018-2021
15.17 ERGOMED PLC
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Financial Analysis
15.17.3.1 Net Revenue, 2016-2020
15.17.3.2 Regional Revenue/Market Shares, 2020
15.17.3.3 Segmental Revenue/Market Shares, 2020
15.17.4 Product Benchmarking
15.17.5 Recent Developments, 2018-2021

16 Conclusion and Recommendations
16.1 Concluding Remarks from
16.2 Recommendations for Market Players
16.3 Leading Regions and Fastest Growing Region (North America Region Accounted for the Largest Market Share)

List of Tables
Table 1 Global Decentralized Clinical Trials Market, 2022 & 2032 (US$ mn, CAGR %)
Table 2 R&D expenditure of Major Pharmaceutical and Biopharmaceutical Companies
Table 3 Global Decentralized Clinical Trials Market Size Forecast: Revenue ($mn), AGR (%), CAGR (%), 2022-2032
Table 4 Global Decentralized Clinical Trials Market Size Forecast: Revenue ($mn), AGR (%), CAGR (%), 2022-2032: "V" Shaped Recovery
Table 5 Global Decentralized Clinical Trials Market Size Forecast: Revenue ($mn), AGR (%), CAGR (%), 2022-2032: "U" Shaped Recovery
Table 6 Global Decentralized Clinical Trials Market Size Forecast: Revenue ($mn), AGR (%), CAGR (%), 2022-2032: "W" Shaped Recovery
Table 7 Global Decentralized Clinical Trials Market Size Forecast: Revenue ($mn), AGR (%), CAGR (%), 2022-2032: "L" Shaped Recovery
Table 8 Global Decentralized Clinical Trials Market Forecast by Study Design, 2022-2032 (US$ million, AGR %, CAGR %)
Table 9 Global Interventional Study Design Segment: Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 10 “V” Shaped Recovery: Global Interventional Study Design Segment: Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 11 “U” Shaped Recovery: Global Interventional Study Design Segment: Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 12 “W” Shaped Recovery: Global Interventional Study Design Segment: Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 13 “L” Shaped Recovery: Global Interventional Study Design Segment: Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 14 Global Observational Study Design Segment: Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 15 “V” Shaped Recovery: Global Observational Study Design Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 16 “U” Shaped Recovery: Global Observational Study Design Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 17 “W” Shaped Recovery: Global Observational Study Design Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 18 “L” Shaped Recovery: Global Observational Study Design Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 19 Global Expanded Access Study Design Segment: Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 20 “V” Shaped Recovery: Global Expanded Access Study Design Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 21 “U” Shaped Recovery: Global Expanded Access Study Design Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 22 “W” Shaped Recovery: Global Expanded Access Study Design Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 23 “L” Shaped Recovery: Global Expanded Access Study Design Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 24 Global Decentralized Clinical Trials Market Size Forecast by Indication, 2022-2032 (US$ million, AGR %, CAGR %)
Table 25 Global Oncology Segment: Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 26 “V” Shaped Recovery: Global Oncology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 27 “U” Shaped Recovery: Global Oncology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 28 “W” Shaped Recovery: Global Oncology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 29 “L” Shaped Recovery: Global Oncology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 30 Global Cardiovascular Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 31 “V” Shaped Recovery: Global oncology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 32 “U” Shaped Recovery: Global Cardiovascular Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 33 “W” Shaped Recovery: Global Cardiovascular Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 34 “L” Shaped Recovery: Global Cardiovascular Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 35 Global Immunology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 36 “V” Shaped Recovery: Global Immunology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 37 “U” Shaped Recovery: Global Immunology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 38 “W” Shaped Recovery: Global Immunology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 39 “L” Shaped Recovery: Global Immunology Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 40 Global Respiratory Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 41 “V” Shaped Recovery: Global Respiratory Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 42 “U” Shaped Recovery: Global Respiratory Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 43 “W” Shaped Recovery: Global Respiratory Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 44 “L” Shaped Recovery: Global Respiratory Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 45 Global Others Segment: Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 46 “V” Shaped Recovery: Global Others Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 47 “U” Shaped Recovery: Global Others Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 48 “W” Shaped Recovery: Global Others Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 49 “L” Shaped Recovery: Global Others Segment, Revenue Forecast 2022-2032 (US$ million, AGR%, CAGR %)
Table 50 Global Decentralized Clinical Trials Market Forecast by End-User, 2022-2032 (US$ mn, AGR%, CAGR %)
Table 51 Global Decentralized Clinical Trials Market for Pharmaceutical & Biopharmaceutical Companies Segment Forecast, 2022-2032 (US$ mn, AGR%, CAGR %)
Table 52 Global Decentralized Clinical Trials Market for Pharmaceutical & Biopharmaceutical Companies Segment Forecast, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 53 Global Decentralized Clinical Trials Market for Pharmaceutical & Biopharmaceutical Companies Segment Forecast, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 54 Global Decentralized Clinical Trials Market for Pharmaceutical & Biopharmaceutical Companies Segment Forecast, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 55 Global Decentralized Clinical Trials Market for Pharmaceutical & Biopharmaceutical Companies Segment Forecast, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 56 Global Decentralized Clinical Trials Market for CROs Segment Forecast, 2022-2032 (US$ mn, AGR%, CAGR %)
Table 57 Global Decentralized Clinical Trials Market for CROs Segment Forecast, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 58 Global Decentralized Clinical Trials Market for CROs Segment Forecast, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 59 Global Decentralized Clinical Trials Market for CROs Segment Forecast, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 60 Global Decentralized Clinical Trials Market for CROs Segment Forecast, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 61 Global Decentralized Clinical Trials Market for Others Segment Forecast, 2022-2032 (US$ mn, AGR%, CAGR %)
Table 62 Global Decentralized Clinical Trials Market for Others Segment Forecast, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 63 Global Decentralized Clinical Trials Market for Others Segment Forecast, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 64 Global Decentralized Clinical Trials Market for Others Segment Forecast, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 65 Global Decentralized Clinical Trials Market for Others Segment Forecast, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 66 Global Decentralized Clinical Trials Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR %)
Table 67 Global Decentralized Clinical Trials Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 68 Global Decentralized Clinical Trials Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 69 Global Decentralized Clinical Trials Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 70 Global Decentralized Clinical Trials Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 71 North America Decentralized Clinical Trials Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR %)
Table 72 North America Decentralized Clinical Trials Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR %)
Table 73 North America Decentralized Clinical Trials Market Forecast by Study Design, 2022-2032 (US$ million, AGR %, CAGR %)
Table 74 North America Decentralized Clinical Trials Market Forecast by Study Design, 2022-2032 (US$ mn, AGR %, CAGR %): "V" Shaped Recovery
Table 75 North America Decentralized Clinical Trials Market Forecast by Study Design, 2022-2032 (US$ mn, AGR %, CAGR %): "U" Shaped Recovery
Table 76 North America Decentralized Clinical Trials Market Forecast by Study Design, 2022-2032 (US$ mn, AGR %, CAGR %): "W" Shaped Recovery
Table 77 North America Decentralized Clinical Trials Market Forecast by Study Design, 2022-2032 (US$ mn, AGR %, CAGR %): "L" Shaped Recovery
Table 78 North America Decentralized Clinical Trials Market Forecast by Indication, 2022-2032 (US$ mn, AGR%, CAGR %)
Table 79 North America Decentralized Clinical Trials Market Forecast by Indication, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 80 North America Decentralized Clinical Trials Market Forecast by Indication, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 81 North America Decentralized Clinical Trials Market Forecast by Indication, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 82 North America Decentralized Clinical Trials Market Forecast by Indication, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 83 North America Decentralized Clinical Trials Market Forecast by End-User, 2022-2032 (US$ mn, AGR%, CAGR %)
Table 84 North America Decentralized Clinical Trials Market Forecast by End-User, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 85 North America Decentralized Clinical Trials Market Forecast by End-User, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 86 North America Decentralized Clinical Trials Market Forecast by End-User, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 87 North America Decentralized Clinical Trials Market Forecast by End-User, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery

Companies Profiled in the Report
CASTOR EDC
Clinical Ink, Inc. (G. I. Partners)
CLOUDZBY, INC.
Dassault SystemesSE (Medidata Solutions, Inc.)
ERGOMED PLC
Florence Healthcare, Inc.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America Holdings (Covance, Inc.)
Medable, Inc.
Medrio Inc.
Oracle Corporation
Parexel International Corporation
Pharmaceutical Product Development, Inc.
Syneos Health

List of Companies Mentioned in the Report
(FMD)
Aastrom Research International
AB Sciex
ABC Laboratories, Inc
ABF Pharmaceutical Services
Abingdon Life Sciences
Abridge
Absorption Systems
Accell Clinical Research
Accelovance
Accelsiors
Accium Biosciences
Accovion
Accumedix, Inc
Accutest Research Organization
Aclires
ACM
ACORN CRO
ACR Image Metrix
Acronet
aCROnordic A/S
Akos
Akrios BioDevelopment International
Albuquerque Clinical Trials (ACT)
AlcheraBio
Alembic
Aliora
Alliance Research Group
Allied Research International
Allphase
AlphaGenesis Incorporated (AGI)
and Consulting
Assign Group
Aviva Fridman Clinical Trials
Axio Research
AXIS Clinicals
AXON
Axon CRO
Axon Medchem
B&C Group
BASi
BBK
Beardsworth
Belnico
Beltas
Biofortis (Silliker)
BioStat International (BSI)
Biotoxtech Co., LTD
Biotrial
Biotrofix
Biovail Contract Research
Biovantix
Blue Sky Biotech
Boston MedTech Advisors
BPI Service Gmbh – Pooling Project Pharmacovigilance
Bradstreet Clinical Research
Bri Biopharmaceutical Research
Catalyst Clinical Services
CATO Research
CCDRD
CCS Associates
Cedarburg Hauser Pharmaceuticals
Celerion
CEMO
Centralabs Clinical Research, Inc (USA)
Cepha
ClinAssure
ClinAudits
ClinBay
Clindatrix
Clinesian Research Management
Clinimetrics
Cogtest Inc
Comac Medical
Commonwealth Biotechnologies
CPR
Cronova
Cropha CRO
Crown CRO
CTO Clinical Trial Operations
CTTI (Clinical Trials TEVA Israel)
Cu-Tech
Cyanta
D2L
Datapharm Australia
Dava Oncology
Davinci Biomedical Research Products, Inc.
DaVita Clinical Research
Dedicated Phase I, Inc.
DevDx Clinical
Developharma
DIL Limited
Dimension Research
Dimensione Ricerca (DR Group)
Discovery Research International (DRI)
Egeen International
Eliapharma Services Inc.
Emergo Group
Emerson Resources
Eminent Research Systems, Inc.
Emissary
Encorium
Endpoint
Ephoran
EpiStat Research
eResearchTechnology, Inc (ERT)
Ergomed
Estern Medical
FOVEA Group
Fractals Clinical Research
GSTT Emergency Scientific and Medical Services
HungaroTrial
Huntingdon Life Sciences (UK)
Hurley Consulting
Hylae Clinical Research
Hyperion Biotechnology
IATEC
ICON Clinical
ICRC-Weyer (Independent Clinical Research Consulting)
ICTS
IFE Baltic UAB
iGATE Clinical Research International
Imperial Clinical Research Services
in Good Clinical Practice)
Inamed
INC Research
Intrinsic Imaging LLC
InVentiv Clinical
iResearch Limited
Iris Pharma
IRW Consulting
IST
Jai Research Foundation (JRF)
JANIX
Jasper
Java Clinical
JSS Medical Research
JSW Life Sciences
Limited
MediCroStar
Medidata Solutions, Inc
Mediolanum Cardio Resesarch (MCR)
Mediprobe Research Inc
Mediscis
Mediserv
Monitoring Force
MPI Research
MSOURCE
MTZ Clinical Research
Nagy Research
Ora Clinical
Oracle
Orange Lifesciences
Orbis Data Solutions
Orion Clinical Services
Oroxcell
Pharm-Olam International (POI)
Pharmaffiliates
Pharmahungary
PharmaIntel
Pharmalog
Pharmalys
Pharmanet
PharmaPart
Pharmatech Oncology
Pharmatek Laboratories, Inc
PharmaTrials, Inc
PharmStats
PharSafer Associates Ltd
Pharsight Corporation
Phaze SA
PHDS Healthcare Research
Phidea /Marvin
PHT Corporation (USA)
Physiogenix
Piedmont
Pierrel
ProInnovera
Prologue Research International
Promedica International
PROMetrika
ProTrials
Radiant Research
RCC Laboratories
RCRI
Recerca Clinica
Registrat-MAPI
Regulatory Clinical Research Institute, Inc (RCRI)
Rejuvendus Clinical Research
Reliance Clinical Research Services (Reliance Life Sciences)
RenaSci
Rephartox
Sanmar Speciality Chemicals Ltd
Service)
SGS Lifesciences
Shandon Clinical Trials
ShangPharma
Shin Nippon Biomedical Laboratories
Siesta Group
Simbec Research
Sinclair Research
Siri Technologies
Siro Clinpharm
SLG (China-CRO)
Smerud Medical Research
SMO-USA
Symphony Pharma Life Sciences
SYNARC/CCBR
Syncare Clinical Services
Synchron
Synexus
SynRG (Synergy Research Group (SRG))
Synteract
Syreon
Sysdata Consulting
TAKE Solutions
TargetHealth
Tata Indicom Ebu (India)
TCG Lifesciences Limited (formerly known as Chembiotek)
Tech Observer
Tetrial, LLC
TGA Sciences, Inc
The Clinical Trial Company (TCTC)
The CRO Group, Inc.
The Patient Recruiting Agency (TPRA)
Universal Research Group
Vital Systems Inc
Vivo Bio Tech Limited
VPS-CRO (VenturePharm Services)
Washington Biotechnology, Inc
Watermark Research Partners
WCCT (West Coast Clinical Trials)
Westat
Winicker Norimed
Worldwide Clinical Trials (WWCT, WCT, CEDRA)
WuXi AppTec
Xceleron
Xendo
ZeinCRO
ZM Company

List of Organizations Mentioned in the Report
ACRF Centre for Advanced Decentralized Clinical Trials
Agencia Nacional de Vigiloncia Sanitaria (ANVISA)
American Cancer Society (ACS)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Center of Excellence in Immunology (CEI)
Centers for Disease Control and Prevention (CDC)
Centers for Medicare & Medicaid Services programs
European Medicines Agency (EMA)
European Union
Experimental Transplantation & Immunotherapy Branch at CCR
Food and Drug Administration (FDA)
French Government
Government of Japan
Health Ministry (Italy)
Indian Council of Medical Research (ICMR)
Institute for Healthcare Improvement (IHI)
International Agency for Research on Cancer (IARC)
Italian Industry Group Farmindustria
Japanese Ministry of Health, Labour and Welfare
Laboratory of Tumor Immunology and Biology at CCR
Medicines and Healthcare Products Regulatory Agency (MHRA)
Ministry of Health, Labour & Welfare (MHLW)
National Cancer Institute (NCI)
National Cancer Institute's Center for Cancer Research (CCR)
National Development and Reform Commission (NDRC)
National Institutes of Health (NIH)
NCBI
NCI's Division of Cancer Biology's Cancer Immunology, Hematology, and Etiology Branch (CIHEB)
The Therapeutic Goods Administration
United Nations (UN)
University of Connecticut
World Health Organization (WHO)
World Population Prospects

$5,119.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports